Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.11999 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.7185 | 73 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.40618 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.78741 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.47641 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.61711 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.21768 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.68578 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.80617 | 74 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.86885 | 74 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.64117 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.76687 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.73564 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.87375 | 75 |